XML 20 R33.htm IDEA: XBRL DOCUMENT

Note 10 - Segment Information (Tables)

6 Months Ended

Jun. 30, 2014

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Three Months Ended June 30,						Six Months Ended June 30,
	2014			2013			2014			2013
Revenues:
Prescription Pharmaceuticals	$	136,231		$	67,362		$	218,079		$	132,508
Consumer Health		14,518			9,650			23,292			18,358

Total revenues		150,749			77,012			241,371			150,866

Gross Profit:
Prescription Pharmaceuticals		68,012			36,743			113,296			70,766
Consumer Health		8,659			5,349			13,031			10,471

Total gross profit		76,671			42,092			126,327			81,237

Operating expenses		60,408			19,841			86,624			40,397

Operating income		16,263			22,251			39,703			40,840
Other (expense)		(1,951	)		(2,269	)		(9,699	)		(4,601	)

Income from continuing operations before income taxes	$	14,312		$	19,982		$	30,004		$	36,239

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details